Видео ютуба по тегу Event: Relapse After Hsct 2021

AML relapse after HSCT: trends and predictive factors
AML relapse after HSCT: trends and predictive factors
Decision-Making in AML: What's Next After Relapse I Dr. Przespolewski - Relapse After Transplant
Decision-Making in AML: What's Next After Relapse I Dr. Przespolewski - Relapse After Transplant
Investigating relapse after allo-SCT in AML
Investigating relapse after allo-SCT in AML
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival..
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival..
Management of relapse after CAR-T in patients with B-cell lymphoma
Management of relapse after CAR-T in patients with B-cell lymphoma
Managing ALL patients who relapse after transplantation
Managing ALL patients who relapse after transplantation
Treating patients relapsed after auto-SCT
Treating patients relapsed after auto-SCT
Outcomes & treatment options for patients with AML who relapse after alloHSCT
Outcomes & treatment options for patients with AML who relapse after alloHSCT
Approaching patients with MDS and AML who relapse after alloSCT & strategies to prevent relapse
Approaching patients with MDS and AML who relapse after alloSCT & strategies to prevent relapse
Outcomes with RIC before second HSCT in secondary AML
Outcomes with RIC before second HSCT in secondary AML
Improving outcomes for patients who relapse after alloSCT & evaluating CD19 CARs against EMD in ALL
Improving outcomes for patients who relapse after alloSCT & evaluating CD19 CARs against EMD in ALL
Treatment After Relapse - T Schroeder
Treatment After Relapse - T Schroeder
Why do patients relapse after transplant? #AML
Why do patients relapse after transplant? #AML
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse
Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after Relapse
Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after Relapse
Conditioning intensity and genomics: relapse after allogeneic transplant in MDS
Conditioning intensity and genomics: relapse after allogeneic transplant in MDS
Prevention, detection and treatment of AML relapse after allo-SCT
Prevention, detection and treatment of AML relapse after allo-SCT
Advances in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (AML)
Advances in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (AML)
Best options for early relapse after undergoing VRd therapy with stem cell transplant
Best options for early relapse after undergoing VRd therapy with stem cell transplant
Management of relapse following alloHSCT in patients with AML and MDS
Management of relapse following alloHSCT in patients with AML and MDS